Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wealthy Families Play A Growing Role in European Biotech Financing

Executive Summary

The continued dearth of venture capital in Europe is highlighting the key role played by wealthy families as an alternative – or at least complementary – source of finance for biopharmaceutical firms.
Advertisement

Related Content

Agennix Halves Headcount, Closes Houston Site, Following Talactoferrin Failure In NSCLC
Sanofi Pasteur, CureVac Sign Infectious Diseases Vaccine Deal, Win U.S. Government Funding
Shrinking Funding Rounds For European Biotechs Are No Surprise, But Series A Rounds Look Healthy, If Few
Shrinking Funding Rounds For European Biotechs Are No Surprise, But Series A Rounds Look Healthy, If Few
Financings Of The Fortnight: Finding Comedy In Today's Financial Environment
Immatics Raises €54 Million Series C To Fund Pivotal Therapeutic Cancer Vaccine Trial
UK Govt. Outlines Hands-Off Approach to Boosting VC
Merck KGaA Buys Serono, Gaining U.S. Commercial Organization
Novartis Boosts Sandoz Generic Business With Acquisition Of Eon, Hexal
Germany's Biotech Bust

Topics

Advertisement
UsernamePublicRestriction

Register

PS053045

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel